Ofloxa-Vision Augensalbe (Ofloxacin)

Ofloxacin belongs to the fluoroquinolone class and works by inhibiting bacterial DNA gyrase and topoisomerase IV. This blocks DNA replication and transcription, leading to bacterial cell death and resolution of the infection.

The dosing regimen for Ofloxa-Vision Augensalbe is determined by the prescribing clinician based on the specific infection, severity, and patient factors. The prescriber will provide detailed instructions on frequency and duration of application.

Safety data for Ofloxa-Vision Augensalbe in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ofloxa-Vision Augensalbe offers broad‑spectrum activity typical of fluoroquinolones, covering many Gram‑negative and Gram‑positive ocular pathogens. Compared with older agents such as chloramphenicol, it generally provides a higher potency and lower resistance risk, though choice depends on local susceptibility patterns and clinician preference.

Store the ointment at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

The ointment is applied topically to the affected eye(s) as directed by the prescriber. Typically, a small amount is placed in the lower conjunctival sac using a clean fingertip or applicator, avoiding contact with the eye surface or eyelashes, and the eyelids are gently closed.

Serious risks, though rare, include severe allergic reactions such as swelling, rash or itching of the eyelids, corneal ulceration, and sudden vision loss. Any of these symptoms require immediate medical attention.

Patients with a known hypersensitivity to Ofloxacin, other fluoroquinolones, or any component of the ointment should avoid its use. Additionally, individuals with active viral or fungal eye infections should not use this antibacterial preparation without specific guidance.